openPR Logo
Press release

Investigation announced for Investors in shares of Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP)

08-14-2019 04:46 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of current long term investors in Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) shares.

An investigation on behalf of current long term investors in Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) shares.

An investigation on behalf of current long-term investors in shares of Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) concerning potential breaches of fiduciary duties by certain directors and officers of Corbus Pharmaceuticals Holdings Inc was announced.

Investors who are current long term investors in Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in NASDAQ: CRBP stocks follows a lawsuit filed against Corbus Pharmaceuticals Holdings over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: CRBP stocks, concerns whether certain Corbus Pharmaceuticals Holdings Inc directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the District of Massachusetts the plaintiff alleges that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between November 14, 2016 and February 28, 2019, the Defendants made false and/or misleading statements, as well as failed to disclose material adverse facts about its drug candidate Lenabasum.

Those who purchased shares of Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in shares of Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) here

News-ID: 1821933 • Views: 295

More Releases from Shareholders Foundation

Investigation announced for Long-Term Investors in NYSE: TAP shares over potenti …
An investigation was announced for current long-term investors in shares of Molson Coors Brewing Company (NYSE: TAP) concerning potential breaches of fiduciary duties by certain directors of Molson Coors Brewing Company. Investors who are current long term investors in Molson Coors Brewing Company (NYSE: TAP) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current
Investigation announced for long-term Investors in shares of Spectrum Brands Hol …
An investigation on behalf of current long-term investors in shares of Spectrum Brands Holdings, Inc. (NYSE: SPB) concerning potential breaches of fiduciary duties by certain directors and officers of Spectrum Brands Holdings, Inc. was announced. Investors who are current long term investors in Spectrum Brands Holdings, Inc. (NYSE: SPB) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a
Deadline on August 26th upcoming in Lawsuit filed for Investors in FedEx Corpora …
The Shareholders Foundation announces that a deadline is coming up on August 26, 2019 in the lawsuit filed for certain investors of FedEx Corporation (NYSE: FDX) over alleged securities laws violations by FedEx. Investors who purchased shares of FedEx Corporation (NYSE: FDX) have certain options and there are strict and short deadlines running. Deadline: August 26, 2019. NYSE: FDX stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779
Lawsuit filed for Investors who purchased shares of 3M Company (NYSE: MMM)
An investor, who purchased shares of 3M Company (NYSE: MMM), filed a lawsuit over alleged violations of Federal Securities Laws by 3M Company in connection with certain allegedly false and misleading statements. Investors who purchased shares of 3M Company (NYSE: MMM) have certain options and for certain investors are short and strict deadlines running. Deadline: September 27, 2019. NYSE: MMM investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)

All 5 Releases


More Releases for Corbus

Dermatomyositis Therapeutics- Pipeline Analysis 2018, Clinical Trials & Results, …
Dermatomyositis is a rare inflammatory disease which can occur in any age. However, it is most common in children age group of 5 to 15 years, and people of late 40's and early 60's. Download the sample report at: https://www.pharmaproff.com/request-sample/1013 Some of the most common symptoms observed in patients with dermatomyositis are erythema, inflammatory myopathy, myalgia, progressive muscle weakness, eyelid abnormality, and periorbital edema. The cause of the disease is still
2019 Procurement Outsourcing Services Market | Accenture, GEP, Genpact, Aquanima …
The report presents the worldwide Procurement Outsourcing Services market report evaluates the growth rate and the market value based on market dynamics, growth inducing factors. The complete knowledge is based on latest industry news, opportunities, and trends. The report contains a comprehensive market analysis and vendor landscape in addition to a SWOT analysis of the key vendors. Download PDF Sample of this Report @ http://www.supplydemandmarketresearch.com/home/contact/205693?ref=Sample-and-Brochure&toccode=SDMRSE205693&utm_source=S2 The key players covered in this study
Procurement Outsourcing Services Market 2019-2025: Share, Size, Trends, Growth, …
Procurement Outsourcing Services Market 2019 Report analyses the industry status, size, share, trends, growth opportunity, competition landscape and forecast to 2025. This report also provides data on patterns, improvements, target business sectors, limits and advancements. Furthermore, this research report categorizes the market by companies, region, type and end-use industry. Get Sample Copy of this Report@ - https://www.researchreportsworld.com/enquiry/request-sample/13981196 Global Procurement Outsourcing Services market 2019 research provides a basic overview of the industry
Process Consulting & Digital Transformation Market will touch a new level in upc …
Digital transformation consulting (DTC) is a policy development and checking strategy service that benefits business managers, leaders and stakeholders. Digital transformation integrates technology into all aspects of a business to positively impact how value is delivered to a customer. The Process Consulting & Digital Transformation market is expected to grow worth of USD +XX Billion and at a CAGR of +X% over the forecast period 2018-2025. The report, titled Global Process
Corbus Platinum sponsor of ATG Insight Live 2008
Corbus, a global leader in Portal Solutions around eCommerce technologies, today announced that it is a platinum sponsor of the ‘ATG Insight Live 2008’. Corbus is an ATG Premier Partner providing solutions, delivering outstanding business value, highest levels of process, and information security for the clients. Corbus has a rich history working with several Fortune 50 companies saving them millions of dollars supporting ATG solutions. Corbus empowers clients by connecting